Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes

AIM: To evaluate the PAQ (®) (CeQur SA, Horw, Switzerland), a wearable 3‐day insulin delivery device that provides set basal rates and bolus insulin on demand, in people with Type 2 diabetes. METHOD: Adults with Type 2 diabetes with HbA(1c) concentrations ≥53 and ≤97 mmol/mol (7.0 and 11.0%) while t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mader, J. K., Lilly, L. C., Aberer, F., Poettler, T., Johns, D., Trautmann, M., Warner, J. L., Pieber, T. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175230/
https://www.ncbi.nlm.nih.gov/pubmed/29888811
http://dx.doi.org/10.1111/dme.13708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175230/
https://www.ncbi.nlm.nih.gov/pubmed/29888811
http://dx.doi.org/10.1111/dme.13708

Ejemplares similares